EPS Bio Technology Corp. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced total revenue was TWD 102.352 million compared to TWD 107.794 million a year ago. Operating income was TWD 10.398 million compared to TWD 3.540 million a year ago. Net income was TWD 6.351 million compared to TWD 4.891 million a year ago. Basic earnings per share was TWD 0.27 compared to TWD 0.21 a year ago. For the nine months, total revenue was TWD 322.372 million compared to TWD 299.364 million a year ago. Operating income was TWD 18.809 million compared to operating loss of TWD 8.394 million a year ago. Net income was TWD 14.850 million compared to net loss of TWD 1.886 million a year ago. Basic earnings per share was TWD 0.62 compared to basic loss per share of TWD 0.08 a year ago.